According to the new market research report "Glycomics/Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027", The glycomics/glycobiology market is projected to reach USD 3.7 Billion by 2027 from USD 1.8 Billion in 2022, at a CAGR of 15.5% during the forecast period.

Browse in-depth TOC on "Glycomics|Glycobiology Market"
376 - Tables
41 - Figures
319 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525

Global Glycomics/ Glycobiology Market Size, Share, Trends and Dynamics

Drivers: Emergence of glycans as biomarkers

Glycans play a vital role in biology; alterations in glycans can lead to dangerous consequences, such as congenital disorders, heart diseases, growth defects, and epilepsy. Research has shown that mutation in glycosyltransferases or related enzymes modifies/alters the glycome and can cause over 100 types of human congenital disorders of glycosylation.

Restraints: Extravagant cost of glycobiology products and tools

The high cost of glycobiology products and instruments like reagents, carbohydrates, mass spectrometers, glycan analysis kits, and enzymes pose an obstacle to their adoption. Developing glycobiology tools requires significant investment; stringent rules and regulations make them even more expensive.

Opportunities: Glycomics applications in precision medicine

Precision medicine has grown rapidly in the last few years. Many pharma and biotech companies are investing heavily to develop targeted drugs that can be used for a specific group of patients. Sugars present on the surface of the cells and complex biomolecules are involved in various processes, including cell recognition and communication. These are crucial processes in inflammation, autoimmune disease, and viral bacterial infections.

Challenges: Lack of skilled workforce

One of the biggest challenges is the lack of skilled workforce engaged in glycobiology research and conduct the process. This is very time consuming, cost ineffective and risky process. Even the staff who handles the glycobiology products are present in scarce. This factor is a biggest obstacle in the market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525

Key Market Players

The global glycomics/glycobiology market is highly competitive. The prominent players operating in this market include Thermo Fisher Scientific (US), New England Biolabs (US), Merck KGaA (Germany), Promega Corporation (US), Waters Corporation (US), Takara Bio Inc, (Japan), Bio-Techne (US), Agilent Technologies (US), Sumitomo Bakelite Co. Ltd. (Japan), Bruker Corporation (US), Shimadzu Corporation (Japan), Danaher Corporation (US), AMS Bio (UK), Ludger Ltd (UK), Z Biotech, LLC (US), Chemily Glycoscience (US), CD BioGlyco (US), GlycoDiag (France), Kode Biotech Limited (New Zealand), Glyxera GmBH (Germany), Lectenz Bio (US), Glycomix Ltd (UK), IEC Group (Italy), Asparia Glycomics (Spain) and Ray Biotech Life Inc. (US) . Product launch, partnerships, collaborations and geographic expansion are the key growth strategies undertaken by these companies to maintain their positions in the market.

Merck KGaA (Germany)

Merck KGaA is also one of the leading players in the glycomics/glycobiology market. The company focuses on inorganic growth strategies such as investment to strengthen its market position. The company invested USD 20.52 Million to build new science laboratory in Switzerland for fostering the experiments and research.

Thermo Fisher  Scientific (US)

Thermo Fisher Scientific held the second position in the glycomics/glycobiology market. The company has entered into collaborations and partnerships with a number of life science companies to develop and promote the use of glycobiology products and is recognized for its contribution in the glycobiology space. TransMIT GmBH (Germany) and OwlStone Medical (UK) are some of the major agreement and collaboration partners of the company.

Agilent Technologies (US)

Agilent Technologies provides a comprehensive portfolio of chromatography systems, along with enzymes, kits, and standards in glycomics/glycobiology market. The company has a strong presence in North America and Europe. The company focuses on product launches and partnerships to maintain its position in the market.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=132685525

Related Reports:

Glycomics/Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com